title: [Preventive measures against postoperative secondary aldosteronism following open heart surgery--planned administration of injective aldosterone antagonist].
authors.forename: R
authors.initials: R
authors.lastname: Shirakura
authors.forename: H
authors.initials: H
authors.lastname: Hirose
authors.forename: S
authors.initials: S
authors.lastname: Nakano
authors.forename: H
authors.initials: H
authors.lastname: Matsuda
authors.forename: M
authors.initials: M
authors.lastname: Ohtani
authors.forename: H
authors.initials: H
authors.lastname: Taniguti
authors.forename: H
authors.initials: H
authors.lastname: Nomura
authors.forename: Y
authors.initials: Y
authors.lastname: Kawashima
mesh_terms: D000328:Adult; D000368:Aged; D002191:Canrenoic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D006348:Cardiac Surgical Procedures; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000517:prevention & control*; D006947:Hyperkalemia / Q000139:chemically induced; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication; D011300:Preoperative Care
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D002191:Canrenoic Acid